Abraxis Oncology
 
Bookmark Send to a Colleague

Patient Resources

Home > Patient Resources > Resources

Resource and Links

For More Information

To find out more about breast cancer and new treatment approaches being developed by Abraxis™ Oncology, please visit www.abraxisbio.com.

More Resources

Below is a list of resources where you can find information about breast cancer and its treatment, patient and survivor advocacy, and a range of other topics. Several professional societies support educational efforts and hold annual national meetings where the latest research in the field of oncology is presented and discussed.

Professional Societies

American Society of Clinical Oncology (ASCO)
American Association for Cancer Research (AACR)
Society of Gynecologic Oncologists (SGO)
Society of Surgical Oncology (SSO)
San Antonio Breast Cancer Symposium

Advocacy Organizations

American Cancer Society (ACS)
breastcancer.org
CANCERCare
Cancer Hope Network
Caring 4 Cancer
Johns Hopkins Avon Foundation Breast Center
Living Beyond Breast Cancer
National Breast Cancer Coalition
National Breast Cancer Foundation
National Coalition for Cancer Survivorship (NCCS)
Patient Advocate Foundation (PAF)
People Living With Cancer
Susan G. Komen Breast Cancer Foundation
SusanLoveMD.org
Y-ME National Breast Cancer Organization

Educational Resources

Association of Cancer Online Resources (ACOR)
CancerLinks
clinicaltrials.gov
National Comprehensive Cancer Network (NCCN)
National Cancer Institute (NCI)
NCI Alliance for Nanotechnology in Cancer
OncoLink
WebMD

Other Resources

ABRAXANE®
Abraxis™ Oncology
NIH Roadmap
Imaginis

In addition to information provided here, be sure to talk to your doctor about other sources of support.

Compliance Declaration Investor Relations Site Map Terms of Use Privacy Policy Glossary Comprehensive Bibliography

Abraxis Oncology is a division of Abraxis BioScience, LLC. AO 997/268353 August 2008
All Abraxis BioScience, LLC corporate names (eg, ABRAXIS, ABRAXIS ONCOLOGY, ABRAXIS BIOSCIENCE, and their logos), names of services, and names of products (eg, ABRAXANE® and the ABRAXANE logo) referred to herein are trade names, service marks and/or trademarks that are owned by or licensed to Abraxis BioScience, its divisions, or its affiliates, unless otherwise noted.

Important Safety Information & Boxed Warning

You should receive ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) under the care of a doctor who is trained to use cancer drugs. Because you may have side effects from your treatment, you should get this medicine in a clinic or hospital with doctors, nurses, and pharmacists who are trained to give cancer drugs.

ABRAXANE therapy should not be given to patients with metastatic breast cancer who have low blood counts. Low blood counts, especially low white blood cell counts, may make you more likely to get an infection. In order to check for low blood counts your doctor may need to take some blood to test your blood counts.

Note: ABRAXANE is paclitaxel made with the human blood protein albumin. This makes it behave differently in the body than regular paclitaxel. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL DRUGS.

Important Safety Information

One of the more important side effects associated with chemotherapy is neutropenia, which is a decrease in the number of infection-fighting white blood cells (neutrophils). Normal levels range from approximately 1,500 cells/mm3 to 1,800 cells/mm3 (but vary according to several factors, such as age and race). If levels fall below 500 cells/mm3, your risk of developing an infection increases and treatment may be interrupted. To avoid the risk of serious infection and fever, your doctor will monitor your absolute neutrophil count (ANC) during therapy.

Women should avoid becoming pregnant while being treated with ABRAXANE. Tell your doctor if you are pregnant, if you become pregnant, or you plan to become pregnant while taking ABRAXANE. Discuss with your doctor how ABRAXANE may affect fertility. Nursing a baby while taking ABRAXANE is not recommended because the drug may be present in breast milk.

The most important adverse events included lower white and red blood cell counts, infections, tingling and numbness, nausea, vomiting, diarrhea, muscle and joint aches, and mouth sores. Other adverse reactions included weakness, visual disturbances, fluid retention, hair loss, and liver and kidney dysfunction. Low platelet counts, allergic reactions (which in rare cases were severe), cardiovascular reactions, and injection site reactions were uncommon.

Sensory neuropathy (numbness, tingling, or burning in the hands and feet) can occur with ABRAXANE and other paclitaxel medications. Severe sensory neuropathy can improve with proper management, as prescribed by your doctor. You should tell your nurse or doctor if you experience numbness, tingling, or burning in your hands or feet while taking ABRAXANE.

Please talk to your doctor or nurse if you have questions regarding the potential side effects of ABRAXANE therapy. You may want to review the Product Information, including Warnings, Precautions, and Contraindications.